Received Sep 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | K7JY3 | — |
on August 26, 2025 a first dose of Bexsero was given to a patient by mistake, patient was supposed to receive Menveo; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 12-year-old female patient who received Men B NVS (Bexsero) (batch number K7JY3, expiry date 30-JUN-2028) for prophylaxis. Co-suspect products included Men ACWY-CRM NVS (Menveo) for prophylaxis. On 26-AUG-2025, the patient received the 1st dose of Bexsero. The patient did not receive Menveo. On 26-AUG-2025, an unknown time after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: on August 26, 2025 a first dose of Bexsero was given to a patient by mistake, patient was supposed to receive Menveo). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.